Therefore, in this study we tested the hypothesis that administering a physiological dose of hAAT to hypertensive diabetic db/db mice will alleviate hypertension by decreasing ENaC and MARCKS protein expression and activity. The gene discussed is MARCKS; the disease is hypertensive disorder.